The analyses of the ex-vivo splenic hilar lymphadenectomy using the retropancreatic approach for advanced proximal gastric cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023943

Enrollment

Unknown

Registered

2019-06-19

Start date

2019-07-01

Completion date

Unknown

Last updated

2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric carcinoma

Interventions

ex-vivo group:the ex-vivo splenic lymphadenectomy using the retropancreatic approach

in--vivo group:laparoscopically splenic lymphadenectomy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 80 years; Confirmed as gastric adenocarcinoma with preoperative biopsy; Stage as T2a-T4, N0-N2b, M0, according to the eighth AJCC; Gastroscopy and other imaging data indicating that the tumor was located at the upper third stomach; Radical excision (R0) could be achieved after preoperative exploration and evaluation; Be tolerant to laparoscopic pneumoperitoneum; Patients and their families agree to participate in clinical trials and sign consent.

Exclusion criteria

Exclusion criteria: Accompanied by obstruction, perforation or haemorrhage etc.; Distal gastric cancer or stump gastric cancer; History of abdominal surgery; Severe cardio-cerebrovascular diseases; History of mental illness.

Design outcomes

Primary

Measure	Time frame
5 year survival;disease free survival;	—

Secondary

Measure	Time frame
No.10 LN;No.11 LN;time of the operation;the morbidity rate;	—

Countries

China

Contacts

Public ContactWu Miao

Department of Gastrointestinal Surgery of the Second People‘s Hospital of SiChuan

13990905852@163.com+86 13990905852

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026